# Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study

> **NCT00352196** · PHASE4 · COMPLETED · sponsor: **Augusta University** · enrollment: 23 (actual)

## Conditions studied

- Asperger's Disorder

## Interventions

- **DRUG:** Risperidone
- **OTHER:** Magnetic Resonance Spectroscopy

## Key facts

- **NCT ID:** NCT00352196
- **Lead sponsor:** Augusta University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2015-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00352196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00352196, "Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00352196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*